In a prospective study of bladder cancer, mutations of the PIK3CA and AKT1 genes, the main players in the PI3K-AKT-mTOR signalling pathway (which plays a significant role in cell growth, proliferation, and survival), were examined. This evidence concerns the gene AKT1 and urinary bladder carcinoma.